CytImmune, Boehringer Ingelheim deal

Boehringer's Boehringer Ingelheim Animal Health (St. Joseph, Mo.) subsidiary licensed CytImmune's nanoparticle drug delivery technology to develop, produce and market tumor-targeted cancer therapeutic...